CULLINAN PEARL
Cullinan Pearl develops an orally available tyrosine kinase inhibitor to target Epidermal Growth Factor Receptor exon 20 mutations. Cullinan Pearl is a subsidiary of Cullinan Oncology.
CULLINAN PEARL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cullinanoncology.com
Status:
Active
Total Funding:
0
Investors List
Cullinan Oncology
Cullinan Oncology investment in Series A - Cullinan Pearl
Taiho Ventures
Taiho Ventures investment in Series A - Cullinan Pearl
Official Site Inspections
http://www.cullinanoncology.com
- Host name: 21.104.215.35.bc.googleusercontent.com
- IP address: 35.215.104.21
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
Loading ... 